Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-Cell activation: Implications for viral immune escape

被引:94
作者
Majumder, B
Janket, ML
Schafer, EA
Schaubert, K
Huang, XL
Kan-Mitchell, J
Rinaldo, CR
Ayyavoo, V
机构
[1] Univ Pittsburgh, Dept Infect Dis & Microbiol, GSPH, Pittsburgh, PA 15261 USA
[2] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA
关键词
D O I
10.1128/JVI.79.13.7990-8003.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Antigen presentation and T-cell activation are dynamic processes involving signaling molecules present in both APCs and T cells. Effective APC function and T-cell activation can be compromised by viral immune evasion strategies, including those of human immunodeficiency virus type 1 (HIV-1). In this study, we determined the effects of HIV-1 Vpr on one of the initial target of the virus, dendritic cells (DC), by investigating DC maturation, cytokine profiling, and CD8-specific T-cell stimulation function followed by a second signal. Vpr impaired the expression of CD80, CD83, and CD86 at the transcriptional level without altering normal cellular transcription. Cytokine profiling indicated that the presence of Vpr inhibited production of interleukin 12 (IL-12) and upregulated IL-10, whereas IL-6 and IL-1 beta were unaltered. Furthermore, DC infected with HIV-1 vpr(+) significantly reduced the activation of antigen-specific memory and recall cytotoxic-T-lymphocyte responses. Taken together, these results indicate that HIV-1 Vpr may in part be responsible for HIV-1 immune evasion by inhibiting the maturation of costimulatory molecules and cytokines essential for immune activation.
引用
收藏
页码:7990 / 8003
页数:14
相关论文
共 68 条
[1]   Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin [J].
Agrawal, A ;
Lingappa, J ;
Leppla, SH ;
Agrawal, S ;
Jabbar, A ;
Quinn, C ;
Pulendran, B .
NATURE, 2003, 424 (6946) :329-334
[2]   Viral mechanisms of immune evasion [J].
Alcami, A ;
Koszinowski, UH .
TRENDS IN MICROBIOLOGY, 2000, 8 (09) :410-418
[3]   HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B [J].
Ayyavoo, V ;
Mahboubi, A ;
Mahalingam, S ;
Ramalingam, R ;
Kudchodkar, S ;
Williams, WV ;
Green, DR ;
Weiner, DB .
NATURE MEDICINE, 1997, 3 (10) :1117-1123
[4]   HIV-1 viral protein R compromises cellular immune function in vivo [J].
Ayyavoo, V ;
Muthumani, K ;
Kudchodkar, S ;
Zhang, DH ;
Ramanathan, P ;
Dayes, NS ;
Kim, JJ ;
Sin, JI ;
Montaner, LJ ;
Weiner, DB .
INTERNATIONAL IMMUNOLOGY, 2002, 14 (01) :13-22
[5]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[6]   Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein [J].
Bartz, SR ;
Vodicka, MA .
METHODS-A COMPANION TO METHODS IN ENZYMOLOGY, 1997, 12 (04) :337-342
[7]   Presentation of exogenous protein antigens on major histocompatability complex class I molecules by dendritic cells: Pathway of presentation and regulation by cytokines [J].
Brossart, P ;
Bevan, MJ .
BLOOD, 1997, 90 (04) :1594-1599
[8]  
Bukrinsky M, 1999, REV MED VIROL, V9, P39, DOI 10.1002/(SICI)1099-1654(199901/03)9:1<39::AID-RMV235>3.0.CO
[9]  
2-3
[10]   Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation [J].
Cella, M ;
Scheidegger, D ;
PalmerLehmann, K ;
Lane, P ;
Lanzavecchia, A ;
Alber, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :747-752